HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)
about
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?The role of ubiquitylation in immune defence and pathogen evasionHuman endogenous retroviruses and the nervous systemHTLV-1 Tax-mediated inhibition of FOXO3a activity is critical for the persistence of terminally differentiated CD4+ T cellsGenes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatment.Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy.NK cells and virus-related cancers.The transcription profile of Tax-3 is more similar to Tax-1 than Tax-2: insights into HTLV-3 potential leukemogenic properties.RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling.Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.Human T-cell leukemia virus type 1 (HTLV-1) tax requires CADM1/TSLC1 for inactivation of the NF-κB inhibitor A20 and constitutive NF-κB signaling.HTLV-1 and innate immunity.Functional Comparison of HBZ and the Related APH-2 Protein Provides Insight into Human T-Cell Leukemia Virus Type 1 Pathogenesis.Human T-cell leukemia/lymphoma virus type 1 p30, but not p12/p8, counteracts toll-like receptor 3 (TLR3) and TLR4 signaling in human monocytes and dendritic cells.A Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated NeuroinflammationDouble control systems for human T-cell leukemia virus type 1 by innate and acquired immunity."Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).Human T-lymphotropic virus proteins and post-translational modification pathwaysLong noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication.A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3.Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases.Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cellsHuman T-cell leukaemia virus type 1: parasitism and pathogenesis.Tumour viruses and innate immunity.Positive and negative regulation of type I Interferons by the human T cell leukemia virus antisense protein HBZ.Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines.
P2860
Q26852683-9E547E20-5D40-449C-A889-C62E3D9846E3Q26860775-F8CB51BA-EEB7-49E2-BBF1-99B1F086004DQ27012467-0D93195A-8162-4D3D-9861-16EA68B8580AQ28542777-E86B1769-5B62-4BBC-87A6-14EA51D989E3Q33713794-7E840EA1-FEBD-4450-9A9F-77BF91853EA5Q33858381-24D3D555-9326-4973-A743-5BAB0913DCD3Q34145669-1C34510C-FD78-490E-A361-7DD2310526D8Q34337237-2B60DB45-C2DB-4891-B750-26972309A9F6Q34387588-E1FD832B-26E1-4288-9AEC-06DFA04CAF53Q34545358-CBE42066-3577-43ED-8E03-D65074531A3BQ35077697-D3E58011-ED4E-4364-8C65-15AF30EE8FC8Q35182251-61FC6567-11B9-4EF7-95C7-3D1AF4B8635FQ35261692-45417EF3-2E97-479A-81DB-FEAD98984C74Q36694078-2B4BBEA0-919C-4425-8DC8-F85B40C55AC1Q37547587-5D34F080-1700-4CD8-993B-B1728EB32227Q37639788-351515C0-1DD2-42D3-A36B-AC31B7CF4C7FQ37827194-1700E43F-BFFC-4595-A9C8-A2449591F9C4Q38055062-B02110D8-B959-496F-9AD7-57029ED120D7Q38156859-6989ED51-F7C8-4CA5-88FC-947EEA8BC7EFQ38765368-D462E96B-9BD7-42B1-BFCD-418662CB1166Q38795250-C9CCC4CF-7872-4D0C-A46A-934CED0CDE9DQ38798967-239EC08F-FFC2-45C4-AF98-BFA7B1B46508Q39088537-32B1D735-2C34-497D-881A-81AF3D447075Q39119670-C31E17E7-E2E1-4841-B430-BDF401450732Q39138332-8DDD1613-984E-444C-9DC1-63EFFBA0A411Q40046615-DB3EDDAC-ABC8-48E2-A047-E1314F6FC954Q40046657-B3EE28B1-3440-439A-9416-14F0007ADA47Q40097549-86A5A1CE-5AB9-484D-920A-5F21022ECCE2Q41381866-21079554-1B9D-4EDF-AF88-C87E0ACF04CB
P2860
HTLV-1 evades type I interferon antiviral signaling by inducing the suppressor of cytokine signaling 1 (SOCS1)
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@ast
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@en
type
label
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@ast
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@en
prefLabel
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@ast
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@en
P2093
P2860
P1433
P1476
HTLV-1 evades type I interfero ...... f cytokine signaling 1 (SOCS1)
@en
P2093
Agnès Lézin
Eduardo Hernandez
Gérard Panelatti
John Hiscott
Meztli Arguello
Peter Wilkinson
Rafick-Pierre Sékaly
Renée Douville
Stéphane Olindo
Stéphanie Olière
P2860
P304
P356
10.1371/JOURNAL.PPAT.1001177
P577
2010-11-04T00:00:00Z